PRESS RELEASE published on 08/25/2025 at 18:30, 9 months 7 days ago Sanofi: Disclosure of trading in own shares
BRIEF published on 08/18/2025 at 18:35, 9 months 14 days ago Sanofi Reports Total Shares and Voting Rights for July 2025 Voting Rights French Commercial Code Shares 2025 Sanofi
PRESS RELEASE published on 08/18/2025 at 18:30, 9 months 14 days ago Sanofi: Information concerning the total number of voting rights and shares - July 2025 Sanofi discloses total voting rights and issued shares as per French commercial and stock market regulations. Details available on their website Voting Rights Shares French Regulations Investor Relations Sanofi
BRIEF published on 08/14/2025 at 07:05, 9 months 18 days ago Sanofi's rilzabrutinib granted orphan drug designation in the EU Sanofi EMA Orphan Drug Rilzabrutinib IgG4 Disease
PRESS RELEASE published on 08/14/2025 at 07:00, 9 months 18 days ago Press Release: Sanofi’s rilzabrutinib earns orphan designation in the EU for IgG4-related disease Sanofi’s rilzabrutinib granted orphan designation in EU for IgG4-related disease. Positive Phase 2 results presented at EULAR 2025 Congress showcasing efficacy and safety profile Sanofi Rilzabrutinib Orphan Designation IgG4-related Disease EULAR 2025
PRESS RELEASE published on 08/11/2025 at 18:30, 9 months 21 days ago Sanofi: Disclosure of trading in own shares
BRIEF published on 08/06/2025 at 07:05, 9 months 26 days ago Sanofi Finalizes Acquisition of Vigil Neuroscience Acquisition Sanofi Neurology Vigil Neuroscience VG-3927
PRESS RELEASE published on 08/06/2025 at 07:00, 9 months 26 days ago Press Release: Sanofi completes the acquisition of Vigil Neuroscience, Inc. Sanofi announces completion of Vigil Neuroscience, Inc. acquisition, reinforcing neurology pipeline with VG-3927 for Alzheimer's. Vigil shareholders receive CVR. VGL101 not acquired Acquisition Sanofi Neurology Alzheimer's Vigil Neuroscience
BRIEF published on 07/22/2025 at 07:35, 10 months 10 days ago Sanofi acquires Vicebio to boost its respiratory vaccine portfolio Sanofi Acquisition Vicebio Respiratory Vaccines Molecular Clamp Technology Biotechnology Investment
PRESS RELEASE published on 07/22/2025 at 07:30, 10 months 10 days ago Press Release: Sanofi to acquire Vicebio, expanding respiratory vaccines pipeline Sanofi acquires Vicebio, enhancing respiratory vaccines pipeline with 'Molecular Clamp' technology and combination vaccine candidates for RSV and hMPV, expanding capabilities in vaccine development Sanofi Vicebio Respiratory Vaccines Molecular Clamp Technology Combination Vaccines
Published on 06/01/2026 at 18:30, 2 hours 20 minutes ago Galaxy Ventures Inc. Enters into Definitive Agreement with TruSilver Metals Corp. to Complete Qualifying Transaction
Published on 06/01/2026 at 15:30, 5 hours 20 minutes ago Karbon-X to Present at the Small Cap Growth Virtual Investor Conference June 4th
Published on 06/01/2026 at 14:30, 6 hours 20 minutes ago Klondike Gold Announces Receipt of Funds from Gold Royalty Payments and Warrants Exercise
Published on 06/01/2026 at 14:00, 6 hours 50 minutes ago Datametrex AI Announces Completion Of Hilco Global Patent Portfolio Qualification Review
Published on 06/01/2026 at 13:30, 7 hours 20 minutes ago Eskay Mining Corp. announces First Targets in its 5,000 meter Drill Program on its Corey-Eskay Property in British Columbia's Golden Triangle
Published on 06/01/2026 at 19:00, 1 hour 50 minutes ago Armen Pogossian Represents Armenia at Forbes Under 30 Summit China, Empowering the Next Generation of Global Entrepreneurs
Published on 06/01/2026 at 17:50, 3 hours ago Alta Group announcement on Voluntary Takeover Offers for Addiko Bank AG
Published on 06/01/2026 at 17:45, 3 hours 5 minutes ago mobilezone completes acquisition of Apfelkiste.ch and retail branding specialist MAREIN
Published on 06/01/2026 at 17:35, 3 hours 15 minutes ago ANUA NAMES KENDALL JENNER AS FIRST-EVER GLOBAL BRAND AMBASSADOR
Published on 06/01/2026 at 18:47, 2 hours 3 minutes ago Disclosure of transactions in own shares from May 25 to May 29, 2026
Published on 06/01/2026 at 18:00, 2 hours 50 minutes ago Covivio - Information on total number of voting rights and share capital
Published on 06/01/2026 at 17:54, 2 hours 56 minutes ago Reporting on share buyback transactions carried out on May 28, 2026
Published on 06/01/2026 at 17:54, 2 hours 56 minutes ago TF1 - Monthly disclosure of the total number of shares and voting rights - May 2026
Published on 06/01/2026 at 17:45, 3 hours 5 minutes ago ENGIE secures €1 billion export financing backed by Euler Hermes
